Related Experiment Videos
Increased valproate serum concentrations upon carbamazepine cessation.
M W Jann1, G S Fidone, M K Israel
1College of Pharmacy, University of Texas, Austin.
Epilepsia
|September 1, 1988
Summary
Discontinuing carbamazepine (CBZ) significantly increased valproate (VPA) serum concentrations in epileptic patients. Monitoring VPA levels is crucial after stopping CBZ to prevent potential toxicity.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Neuroscience
Background:
- Carbamazepine (CBZ) is an enzyme-inducing antiepileptic drug.
- Valproate (VPA) is a widely used antiepileptic medication.
- Drug interactions can alter serum concentrations of antiepileptic drugs.
Purpose of the Study:
- To investigate the effect of carbamazepine (CBZ) discontinuation on valproate (VPA) serum concentrations.
- To determine the time course of VPA serum concentration changes after CBZ withdrawal.
Main Methods:
- Serum valproate concentrations (Cp) were monitored in six epileptic patients with mental retardation.
- Carbamazepine (CBZ) was discontinued during the study period.
Main Results:
- Valproate (VPA) serum concentrations (Cp) significantly increased after carbamazepine (CBZ) discontinuation.
- A new steady-state VPA Cp was reached approximately 4 weeks post-CBZ withdrawal.
- The observed pharmacokinetic changes are consistent with CBZ's autoinduction properties.
Conclusions:
- Discontinuation of carbamazepine (CBZ) leads to a significant increase in valproate (VPA) serum concentrations.
- Close monitoring of VPA Cp is recommended when discontinuing CBZ or other enzyme-inducing agents.
- Understanding drug interactions is vital for optimizing antiepileptic drug therapy.